The President of the Irish Medical Organisation has said reading the Scally Report into the CervicalCheck crisis has been "incredibly informative".
Speaking on RTÉ's This Week, Dr Peadar Gilligan commended Dr Scally and his team and said the report clarifies "lots of issues".
He said the report reconfirms the importance of the CervicalCheck service and of the audit of the screening programme.
He said that time now needs to be set aside to explain the detail of the "adverse event" that has happened.
The failure of doctors to disclose information to patients was a central feature of the report and when they did disclose it some doctors were accused of being insensitive, hurtful and even misogynistic.
In response to this, Dr Gilligan said "clearly things were said in the consultation that I think on reflection those doctors probably would not have said or would have put in a very different way."
"I think it is very important in the context of disclosure however that the appropriate resources are put in place, and by that I mean time has to be set aside to explain the detail of the adverse event that has happened".
The Scally Review was published on 12 September and found "serious gaps" in expertise and governance of the CervicalCheck screening programme.
The scoping inquiry in the CervicalCheck screening programme was set up to examine the non-disclosure of information to patienst and the apparent widespread practice of non-disclosure, and who knew this was happening.
The controversy came to light after Vicky Phelan, from Annacotty, Co Limerick, along with her husband Jim Phelan sued the Health Service Executive and Clinical Pathology Laboratories Inc, Austin, Texas, over a smear test taken under the National Cervical Screening Programme CervicalCheck and analysed in the US laboratory.
She was diagnosed with cancer three years after her smear test results of 2011 were incorrectly reported as clear of abnormalities.
By the time she had another smear test in 2014 she had cervical cancer.
Since then it has emerged that more than 200 women with cervical cancer should have received treatment earlier than they did.